A biomarker describes a measurable indicator of a patient's clinical condition that can be
measured accurately and reproducibly. Biomarkers offer utility for diagnosis, prognosis …

Background Sepsis and septic shock remain drivers for mortality in critically ill patients. The
heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality …

Background There is a lack of validated tools to assess potential disease progression and
hospitalisation decisions in patients presenting to the emergency department (ED) with a …

Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …

Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the
evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis …

Adrenomedullin (AM) is a vasodilative peptide with various physiological functions,
including the maintenance of vascular tone and endothelial barrier function. AM levels are …

Early identification and diagnosis of sepsis and septic shock is vitally important; despite
appropriate management, mortality and morbidity rates remain high. For this reason, many …

Background Numerous biomarkers have been proposed for diagnosis, therapeutic, and
prognosis in sepsis. Previous evaluations of the value of biomarkers for predicting mortality …

Objectives Midregional pro-adrenomedullin (MR-proADM) is a vasoactive peptide with key
roles in reducing vascular hyperpermeability and thereby improving endothelial stability …

The widespread endothelial damage due to severe acute respiratory syndrome coronavirus
2 (SARS‐CoV‐2) may lead to a disruption of the adrenomedullin (ADM) system responsible …